Federica Cavallo
Università degli Studi di Torino
H-index: 60
Europe-Italy
Top articles of Federica Cavallo
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Non-Hodgkin lymphoma treated with anti-CD20 antibody-based immunochemotherapy | Michele Clerico Simone Ragaini Federica Cavallo | 2024/1/1 | |
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response | Nature Communications | Vincenzo Salemme Mauro Vedelago Alessandro Sarcinella Federico Moietta Alessio Piccolantonio | 2023/5/11 |
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma | Blood Advances | Annalisa Arcari Lugi Rigacci Alessandra Tucci Benedetta Puccini Sara Veronica Usai | 2023/8/8 |
Adamantinoma-like Ewing sarcoma of the salivary glands: a case report and systematic literature review | Therapeutic Advances in Medical Oncology | Eleonora Lauricella Anna Manicone Federica Cavallo Gian Paolo Dagrada Giovanni Centonze | 2023/4 |
A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma | Molecular Therapy | Lidia Tarone Davide Giacobino Mariateresa Camerino Lorella Maniscalco Selina Iussich | 2023/8/2 |
A chimeric Human/Dog CSPG4 DNA vaccine reveals potential therapeutic effects for the treatment of melanoma | CANCERTO-NANOSCIENCE IN CANCER IMMUNOTHERAPY | Federica Riccardo Lidia Tarone Davide Giacobino Mariateresa Camerino Giuseppina Barutello | 2023/3/29 |
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial | Blood advances | Simone Ferrero Daniele Grimaldi Elena Arrigoni Mariapia Pironti Gian Maria Zaccaria | 2023/7/25 |
Maternal immunization against ALK: A new weapon against Neuroblastoma | CANCERTO-NANOSCIENCE IN CANCER IMMUNOTHERAPY | Giuseppina Barutello Federica Riccardo Claudia Voena Giulia Peppino Elisabetta Bolli | 2023/3/29 |
Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease | Frontiers in Immunology | Seok-Chan Park Laura Conti Valentina Franceschi Byungkwan Oh Myeon-Sik Yang | 2023/7/6 |
829 A potent STING agonist in combination with a novel anti-PD-L1/PD-L2 antibody leads to significant tumor responses in checkpoint-refractory cancers | Ahmad Salameh Laura Conti Elisabetta Bolli Chiara Cossu Manuela Iezzi | 2023/11/1 | |
The definitive version is available at | Silvia Chiesa Susanna Schmidt Carla Tinti Cesare Cornoldi | ||
Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models | Journal of Experimental & Clinical Cancer Research | Roberto Ruiu Chiara Cossu Antonella Iacoviello Laura Conti Elisabetta Bolli | 2023/9/29 |
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis | Biomedicines | Marco Macagno Silvio Bandini Elisabetta Bolli Amanda Bello Federica Riccardo | 2022/1/21 |
Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights | Frontiers in Oncology | Chiara Salvetti Candida Vitale Valentina Griggio Daniela Drandi Rebecca Jones | 2022/6/6 |
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment | Cancers | Enza Di Gregorio Chiara Romiti Antonino Di Lorenzo Federica Cavallo Giuseppe Ferrauto | 2022/12/20 |
Immunotherapy against the cystine/glutamate antiporter xCT improves the efficacy of APR-246 in preclinical breast cancer models | Biomedicines | Giuseppina Barutello Antonino Di Lorenzo Alessandro Gasparetto Chiara Galiazzi Elisabetta Bolli | 2022/11/8 |
Role and involvement of Tenm4 and miR-708 in breast cancer development and therapy | Giulia Peppino Federica Riccardo Maddalena Arigoni Elisabetta Bolli Giuseppina Barutello | 2022/1/5 | |
Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy? | Frontiers in Oncology | Roberto Ruiu Antonino Di Lorenzo Federica Cavallo Laura Conti | 2022/4/21 |
HER2-displaying M13 bacteriophages induce therapeutic immunity against breast cancer | Cancers | Junbiao Wang Alessia Lamolinara Laura Conti Mara Giangrossi Lishan Cui | 2022/8/22 |
Post-transplant lymphoproliferative disease (PTLD) after allogeneic hematopoietic stem cell transplantation: biology and treatment options | Michele Clerico Irene Dogliotti Andrea Aroldi Chiara Consoli Luisa Giaccone | 2022/12/19 |
Co-Authors
